Welcome
Dear Colleagues,
It is with great pleasure and honor that we warmly invite you to the 4th International Congress of Hypertension in Children, Adolescents and Young Adults (ICHCA 2026), to be held in the historic city of Prague, Czech Republic, from 7–9 May 2026.
As we prepare for this congress in one of world´s most beautiful cultural centers belonging to the UNESCO world heritage cities, we find ourselves at a critical point in our field. The increasing prevalence of hypertension in children and cardiovascular disease calls for a deeper understanding of its origins and progression—beginning as early as childhood, and in some cases, even prenatally. Our collective efforts must focus on early identification and the development of strategies to prevent and mitigate long-term impact.
Arterial hypertension is the most significant potentially reversible risk factor for cardiovascular disease. With both primary and secondary forms often manifesting in young patients including children and adolescents, and involving a wide range of underlying causes, this condition crosses the boundaries of numerous medical specialties such as cardiology or nephrology. In recent decades, we have seen rapid advancements in both pharmacological and interventional treatments that have reshaped pediatric hypertension care.
Building on the success of previous three ICHCA meetings, the 4th ICHCA Congress will explore a broad range of topics—from prenatal programming, pathogenesis and clinical management to the latest therapeutic developments. The program will include:
- Case-based panel discussions and real-world clinical challenges
- Updates on novel pharmacological and invasive therapies
- Debates on diagnostic and classification standards
- Strategies for transitioning adolescents into adult hypertension care
This congress is designed for pediatricians, family physicians, pediatric cardiologists, pediatric nephrologists, and all professionals involved in managing hypertension and preventing cardiovascular disease in children, adolescents and young adults.
It will also provide the possibility to meet new friends and to interact with faculty, experts in the field of pediatric hypertension.
We look forward to insightful discussions, groundbreaking presentations, and the strengthening of collaborations that will move our specialty forward. Let’s shape the future of pediatric hypertension care—together.
See you in Prague!
Warm regards,
Prof Mieczysław Litwin, Poland
Prof Tomáš Seeman, Czech Republic
Chairs, ICHCA 2026
On behalf of the Scientific Committee
Who should attend
The congress welcomes participation from experts and professionals in the following fields:
Whether you're a clinician, researcher, industry leader, or policy advocate, this congress offers a platform to exchange knowledge, present innovations, and drive forward the global conversation on hypertension and cardiometabolic health in young populations.
Medical & Scientific Disciplines
- Cardiology (Pediatric & Adult)
- Hypertension
- Nephrology & Pediatric Nephrology
- Endocrinology
- Diabetes
- Obesity
- Dyslipidemia
- Nutrition & Clinical Nutrition
- Internal Medicine
- Family Medicine
- Pediatrics & Adolescent Medicine
- Epidemiology & Public Health
- Clinical Trials & Translational Research
- Pharmacology & Clinical Pharmacology
- Genetics & Genomic Medicine
- Sleep Medicine
- Behavioral Medicine & Psychology
- Developmental Pediatrics
Diagnostics, Technology & Imaging
- Imaging (Innovative & Routine Methods)
- Diagnostics & Biomarkers
- Digital Health & Health Informatics
- Remote Monitoring & Wearable Technologies
Health & Allied Health Professionals
- Nurses & Nurse Practitioners
- Dietitians & Nutritionists
- Pharmacists
- Physical Activity & Exercise Professionals
- Health Educators & Community Health Workers
Industry & Research
- Pharmaceutical & Biotech Companies
- Medical Device Manufacturers
- Clinical Research Organizations (CROs)
- Health Tech Startups
- Policy Makers & Advocacy Groups
- Academic and Research Institutions